Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Departing Words: Merck’s Ken Frazier Cautions Against Profit Maximization

Nov 17 2022

• By Sarah Karlin-Smith

Kenneth Frazier, Chairman of the Board and CEO of US pharmaceutical company Merck looks on during an event with the French-American Foundation in Paris on July 11, 2018. (Photo by ERIC PIERMONT / AFP) GettyImages-996036844 — • Source: Eric Piermont/AFP via Getty Images

Related Content

Cancer Drugs And Medicare: Range Of Impacts Expected From IRA Price Reforms

Nov 09 2022

Merck’s Frazier Urges Businesses To Use ‘Every Instrument At Their Disposal’ To Reduce Racial Inequity

Jun 03 2020

Industry In The Middle: Merck's Frazier Takes A Stand, Trump Tweets Back

Aug 14 2017

Related Companies

Merck & Co., Inc.

Additional Topics

United States Leadership Pricing Debate Politics Business Strategies Pricing Strategies Commercial Policy BioPharmaceutical

More from Agency Leadership

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window